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Methylphenidate ([M], Ritalin®) is used in
the pharmacologic management ofhyperac-
tive children, using doses from 0.5 to 2
mg/kg/day. Since there are few published
reports on the reproductive toxicity ofthis
compound, this study was performed using
the RACB protocol in Swiss CD-1 mice. In
a previous NTP subchronic study ofM in
B6C3F1 mice, dietary levels of greater than
125 ppm reduced sperm motility, while
hepatitis was observed at levels greater than
or equal to 250 ppm. Thus, dietary concen-
trations of0.012, 0.05, and 0.1% in feed
were selected for the current study (125,
500, and 1000 ppm).
Body weight was occasionally reduced
for males at thehigh dose (byapproximately
6%) but not for females at any dose. Feed
consumption was not affected by M addi-
tion. Body weights and feed consumption
measures permit the calculation ofdaily
dose estimates: 18,75, and 160 mg/kg/day.
The nine deaths during thestudy all showed
differing patterns ofeffects, and were judged
to be not treatment related.
These levels of M in the feed did not
change the number oflitters per pair, the
number of pups per litter, pup viability, or
pup weight. Cumulative days to litter were
not changed by M treatment.
The last litter from Task 2 was reared
and began M treatment after weaning. Pup
viability and growth to weaning was not
affected bymaternal M consumption.
After the last litter was weaned, the high
dose and control Fo mice were killed and
necropsied. Female terminal body weights
were unchanged, while adjusted liver weight
was increased in the treated mice byapproxi-
mately 20%. Ante-mortem cyclicity mea-
sures found no M-related change in the
estrous cyde.
Male terminal body weight was reduced
by approximately 10%, and adjusted liver
weight was increased by aproximately 19%.
There were no changes in other organ
weights. Epididymal sperm abnormalities
were reduced from a control value of
approximately 5%, to approximately 3% in
the M-treated males; while statistically sig-
nificant, this is probably oflittle or no bio-
logical import.
Since there were no adverse reproduc-
tive effects in Task 2, only the high dose
group and controls were evaluated in the
second generation. During this matingtrial,
there were no treatment-related changes in
the percent ofpairs mating or delivering
young, just as there were no reductions in
the number oflive pups per litter, their
viability, ortheirbodyweight.
Once the F2 litters had been evaluated,
all mice were killed and the Fl parents
necropsied. Female terminal body weight
was unchanged by 0.1% M consumption,
but adjusted liver, kidney, and ovary
weights were increased, by 17, 6, and 18%,
respectively. There was no M-related ante-
mortem change in estrous cyclicity. Male
body weights were unaffected by 0.1% M
consumption, though adjusted liver weight
was increased by approximately 20%, and
seminal vesicle weight was reduced by
13%. There were no changes in epididy-
mal sperm measures.
These data show that these levels of
methylphenidate in the diet ofSwiss CD-1
mice caused effectively no change in repro-
ductive end points, despite changes in liver
weights and male body weights. Although
hepatic and body weight changes seen in
the previous 90-day subchronic study were
mirrored in this RACB study, the previ-
ous reductions in sperm motility were not
reproduced. One possible explanation for
this is the use of different mouse strains,
but this is hypothetical and deserves
further investigation.
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Summary: NTP Reproductive Assessment by Continuous Breeding Study.
NTIS#: PB89178057/AS
Chemical: Methylphenidate Hydrochloride
CAS#: 298-59-9
Mode of exposure: Feed
Species/strain: Swiss CD-1 mice
F generation Dose concentraton 0.012% 0.05% 0.1%
Bodyweight _ _ , __-_-_1,-
Kidneyweighta _ --
Liverweight8 . . t,I'
Mortality .- _ -.- _ ,
Feedconsumption .- -
Waterconsumption _
Clinical signs _ -. ___--_--
litters/pair -
#livepups/litter pupwt./litter - __
Cumulativedays to litter _
Absolutetestis, epididymisweight' .
Sexaccessoryglandweight'(prostate, seminalvesicle) . *
Epidid. spermparameters (#,motility, morphology) _ * ______.... -___-___-_____
Estrous cycle length
[Determination ofaffected sex(crossover) Male Female Both
Dose level j * 1 * 1I _ e _ _
F generation Dose concentration 0.012% 0.05% 0.1%
Pup growthtoweaning _ , ,-
Mortality
Adultbodyweight
Kidneyweight'
a
Liverweight'
Feedconsumption . -
Water consumption . .
Clinical signs * _ - -
Fertility index e .
#live pups/litter; pupwt./litter *
Absolutetestis, epididymisweight' . _ . .
Sexaccessoryglandweight'(prostate, seminalvesicle) . _
Epidid. spermn parameters(#,motility, morphology) . ,
Estrous cycle length _ * __
Affected sex? Unclear
Studyconfounders: None
NOAELrepmductivetoxicity: 0.1%
NOAELgeneraltoxicity: <0.1%
F1 moresensitivethanF0? No
Postnataltoxicity: No
Legend: -, no change; *, no observation; 1' or4-, statistically significantchange (p<0.05); , nochange in males orfemales. 'Adjusted forbodyweight.
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